ProShares UltraShort Bloomberg Natrl Gas

MicroSectors Gold Miners 3X Leveraged ETN

Bank Of Montreal

Direxion Daily Gold Miners Bull 3X ETF

Direxion Daily Technology Bull 3X ETF

Direxion Daily Financial Bull 3X ETF

VanEck Vectors Junior Gold Miners ETF

VanEck Vectors Gold Miners ETF

Guggenheim Solar ETF

ProShares UltraPro Dow30

ProShares Ultra Bloomberg Natural Gas

United States Natural Gas

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Direxion Daily Gold Miners Bear 3X ETF

Direxion Technology Bear 3X Shares

Direxion Financial Bear 3X Shar

Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily 20+ Yr Trsy Bear 3X ETF

Juniper Networks Inc. Common Stock

Reddit Inc. Class A Common Stock

Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share)

Oracle Corporation Common Stock

Whirlpool Corporation Common Stock

Arista Networks Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Gold Fields Limited American Depositary Shares

Goldman Sachs Group Inc. (The) Common Stock

ChargePoint Holdings Inc. Common Stock

RE/MAX Holdings Inc. Class A Common Stock

Boston Properties Inc. Common Stock

Thor Industries Inc. Common Stock

Chewy Inc. Class A Common Stock

Asbury Automotive Group Inc Common Stock

Ryman Hospitality Properties Inc. (REIT)

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

The AZEK Company Inc. Class A Common Stock

Quaker Houghton Common Stock

Click here to get full coverage on BMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT - MSN

BMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT  MSN

BMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT - MSN

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Price Target Raised by Wells Fargo | ALNY Stock News - GuruFocus

Alnylam Pharmaceuticals (ALNY) Price Target Raised by Wells Fargo | ALNY Stock News  GuruFocus

Alnylam Pharmaceuticals (ALNY) Price Target Raised by Wells Fargo | ALNY Stock News - GuruFocus

Click here to get full coverage on $1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today  Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga

Click here to get full coverage on When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable? - Yahoo Finance

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable?  Yahoo Finance

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable? - Yahoo Finance

Click here to get full coverage on Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference - Business Wire

Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference  Business Wire

Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference - Business Wire

Click here to get full coverage on Notable ETF Outflow Detected - XBI, INSM, ALNY, BPMC - Nasdaq

Notable ETF Outflow Detected - XBI, INSM, ALNY, BPMC  Nasdaq

Notable ETF Outflow Detected - XBI, INSM, ALNY, BPMC - Nasdaq

Click here to get full coverage on Breakthrough: New ATTR Amyloidosis Drug AMVUTTRA Shows 36% Lower Mortality in EU Approval - Stock Titan

Breakthrough: New ATTR Amyloidosis Drug AMVUTTRA Shows 36% Lower Mortality in EU Approval  Stock Titan

Breakthrough: New ATTR Amyloidosis Drug AMVUTTRA Shows 36% Lower Mortality in EU Approval - Stock Titan

Click here to get full coverage on Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase - simplywall.st

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase  simplywall.st

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase - simplywall.st

Click here to get full coverage on Needham Raises Price Target for Alnylam Pharmaceuticals (ALNY) to $377 | ALNY Stock News - GuruFocus

Needham Raises Price Target for Alnylam Pharmaceuticals (ALNY) to $377 | ALNY Stock News  GuruFocus

Needham Raises Price Target for Alnylam Pharmaceuticals (ALNY) to $377 | ALNY Stock News - GuruFocus

Click here to get full coverage on Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report - Yahoo Finance

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report  Yahoo Finance

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report - Yahoo Finance

Click here to get full coverage on Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results - Business Wire

Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results  Business Wire

Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results - Business Wire

Click here to get full coverage on Growth Stock Portfolio: 12 Companies with At Least 30% Annual Growth Rates - Insider Monkey

Growth Stock Portfolio: 12 Companies with At Least 30% Annual Growth Rates  Insider Monkey

Growth Stock Portfolio: 12 Companies with At Least 30% Annual Growth Rates - Insider Monkey

Click here to get full coverage on Earnings Preview: RNAi Leader Alnylam Set to Unveil Q1 2025 Performance May 1 - What to Watch - Stock Titan

Earnings Preview: RNAi Leader Alnylam Set to Unveil Q1 2025 Performance May 1 - What to Watch  Stock Titan

Earnings Preview: RNAi Leader Alnylam Set to Unveil Q1 2025 Performance May 1 - What to Watch - Stock Titan

Click here to get full coverage on Needham Raises Alnylam (ALNY) Price Target to $377 | ALNY Stock News - GuruFocus

Needham Raises Alnylam (ALNY) Price Target to $377 | ALNY Stock News  GuruFocus

Needham Raises Alnylam (ALNY) Price Target to $377 | ALNY Stock News - GuruFocus

Click here to get full coverage on Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ...  Yahoo Finance

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on Alnylam Issues 2024 Corporate Responsibility Report - Business Wire

Alnylam Issues 2024 Corporate Responsibility Report  Business Wire

Alnylam Issues 2024 Corporate Responsibility Report - Business Wire

Click here to get full coverage on European Approval Expansion for Alnylam's (ALNY) AMVUTTRA | ALNY Stock News - GuruFocus

European Approval Expansion for Alnylam's (ALNY) AMVUTTRA | ALNY Stock News  GuruFocus

European Approval Expansion for Alnylam's (ALNY) AMVUTTRA | ALNY Stock News - GuruFocus

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Price Target Raised by BMO Capital | ALNY Stock News - GuruFocus

Alnylam Pharmaceuticals (ALNY) Price Target Raised by BMO Capital | ALNY Stock News  GuruFocus

Alnylam Pharmaceuticals (ALNY) Price Target Raised by BMO Capital | ALNY Stock News - GuruFocus

Click here to get full coverage on Alnylam (ALNY) Price Target Boosted to $360 by BMO Capital | ALNY Stock News - GuruFocus

Alnylam (ALNY) Price Target Boosted to $360 by BMO Capital | ALNY Stock News  GuruFocus

Alnylam (ALNY) Price Target Boosted to $360 by BMO Capital | ALNY Stock News - GuruFocus

Click here to get full coverage on Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress - Business Wire

Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress  Business Wire

Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress - Business Wire

Click here to get full coverage on Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q1 Earnings Expected to Decline - Yahoo Finance

Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q1 Earnings Expected to Decline  Yahoo Finance

Earnings Preview: Alnylam Pharmaceuticals (ALNY) Q1 Earnings Expected to Decline - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability - Yahoo Finance

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability  Yahoo Finance

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (NasdaqGS:ALNY) Celebrates FDA Approval of Qfitlia Despite 5% Share Price Dip - Yahoo Finance

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Celebrates FDA Approval of Qfitlia Despite 5% Share Price Dip  Yahoo Finance

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Celebrates FDA Approval of Qfitlia Despite 5% Share Price Dip - Yahoo Finance

Click here to get full coverage on Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last? - Yahoo Finance

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last?  Yahoo Finance

Alnylam (ALNY) Moves 8.5% Higher: Will This Strength Last? - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Click here to get full coverage on Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance

Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics  Yahoo Finance

Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Price Target Raised to $500 by H.C. Wainwright - Insider Monkey

Alnylam Pharmaceuticals (ALNY) Price Target Raised to $500 by H.C. Wainwright  Insider Monkey

Alnylam Pharmaceuticals (ALNY) Price Target Raised to $500 by H.C. Wainwright - Insider Monkey

Click here to get full coverage on Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...  Yahoo Finance

Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Click here to get full coverage on Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires? - Insider Monkey

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires?  Insider Monkey

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Long Term Growth Stock to Buy According to Billionaires? - Insider Monkey

Click here to get full coverage on Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster (NASDAQ:ALNY) - Seeking Alpha

Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster (NASDAQ:ALNY)  Seeking Alpha

Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster (NASDAQ:ALNY) - Seeking Alpha

Click here to get full coverage on Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer - Business Wire

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer  Business Wire

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer - Business Wire

Click here to get full coverage on Morgan Stanley Lowers Alnylam (ALNY) Price Target Amid Earnings Preview | ALNY Stock News - GuruFocus

Morgan Stanley Lowers Alnylam (ALNY) Price Target Amid Earnings Preview | ALNY Stock News  GuruFocus

Morgan Stanley Lowers Alnylam (ALNY) Price Target Amid Earnings Preview | ALNY Stock News - GuruFocus

Click here to get full coverage on GILD vs. ALNY: Which Stock Is the Better Value Option? - Yahoo Finance

GILD vs. ALNY: Which Stock Is the Better Value Option?  Yahoo Finance

GILD vs. ALNY: Which Stock Is the Better Value Option? - Yahoo Finance

Click here to get full coverage on Is Alnylam Pharmaceuticals (NASDAQ:ALNY) A Risky Investment? - simplywall.st

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) A Risky Investment?  simplywall.st

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) A Risky Investment? - simplywall.st

Click here to get full coverage on Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth Healthcare Stocks to Invest In Now? - Yahoo Finance

Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth Healthcare Stocks to Invest In Now?  Yahoo Finance

Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth Healthcare Stocks to Invest In Now? - Yahoo Finance

Click here to get full coverage on ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals - Yahoo Finance

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals  Yahoo Finance

ALNY Announces Preliminary 2024 Results, 2025 View & Pipeline Goals - Yahoo Finance

Click here to get full coverage on Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More - Yahoo Finance

Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More  Yahoo Finance

Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More - Yahoo Finance

Click here to get full coverage on Alnylam (ALNY) Names New Chief R&D Officer to Drive Innovation | ALNY Stock News - GuruFocus

Alnylam (ALNY) Names New Chief R&D Officer to Drive Innovation | ALNY Stock News  GuruFocus

Alnylam (ALNY) Names New Chief R&D Officer to Drive Innovation | ALNY Stock News - GuruFocus

Click here to get full coverage on Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025 - Seeking Alpha

Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025  Seeking Alpha

Alnylam Pharmaceuticals: Commercialization And Early-Stage Studies Are Likely To Drive 2025 - Seeking Alpha

Click here to get full coverage on Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires? - Insider Monkey

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires?  Insider Monkey

Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Growth Stock to Buy According to Billionaires? - Insider Monkey

Click here to get full coverage on Alnylam's Vutrisiran FDA Review Set for ATTR-CM Treatment Expansion - Stock Titan

Alnylam's Vutrisiran FDA Review Set for ATTR-CM Treatment Expansion  Stock Titan

Alnylam's Vutrisiran FDA Review Set for ATTR-CM Treatment Expansion - Stock Titan

Click here to get full coverage on ALNY Stock: JP Morgan Raises Price Target to $338 | ALNY Stock N - GuruFocus

ALNY Stock: JP Morgan Raises Price Target to $338 | ALNY Stock N  GuruFocus

ALNY Stock: JP Morgan Raises Price Target to $338 | ALNY Stock N - GuruFocus

Click here to get full coverage on Alnylam Pharmaceuticals, Inc. (ALNY): Among the Best Growth Stocks to Buy and Hold for the Long Term - Insider Monkey

Alnylam Pharmaceuticals, Inc. (ALNY): Among the Best Growth Stocks to Buy and Hold for the Long Term  Insider Monkey

Alnylam Pharmaceuticals, Inc. (ALNY): Among the Best Growth Stocks to Buy and Hold for the Long Term - Insider Monkey

Click here to get full coverage on Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress - Business Wire

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress  Business Wire

Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress - Business Wire

Click here to get full coverage on Buy, Sell, Or Hold Alnylam Stock At $280? - Forbes

Buy, Sell, Or Hold Alnylam Stock At $280?  Forbes

Buy, Sell, Or Hold Alnylam Stock At $280? - Forbes

Click here to get full coverage on Revolutionary Hemophilia Treatment Achieves 90% Bleed Reduction in FDA Approval - Stock Titan

Revolutionary Hemophilia Treatment Achieves 90% Bleed Reduction in FDA Approval  Stock Titan

Revolutionary Hemophilia Treatment Achieves 90% Bleed Reduction in FDA Approval - Stock Titan

Click here to get full coverage on Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference - Business Wire

Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference  Business Wire

Alnylam to Webcast Presentation at Needham 24th Annual Virtual Healthcare Conference - Business Wire

Click here to get full coverage on JPMorgan Ups Price Target for Alnylam (ALNY) Following Amvuttra Forecast Revision | ALNY Stock News - GuruFocus

JPMorgan Ups Price Target for Alnylam (ALNY) Following Amvuttra Forecast Revision | ALNY Stock News  GuruFocus

JPMorgan Ups Price Target for Alnylam (ALNY) Following Amvuttra Forecast Revision | ALNY Stock News - GuruFocus

Click here to get full coverage on Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day - Business Wire

Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day  Business Wire

Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day - Business Wire

Click here to get full coverage on Alnylam (ALNY) Secures EU Approval for Amvuttra in Cardiomyopathy - GuruFocus

Alnylam (ALNY) Secures EU Approval for Amvuttra in Cardiomyopathy  GuruFocus

Alnylam (ALNY) Secures EU Approval for Amvuttra in Cardiomyopathy - GuruFocus

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY): Among the Oversold Biotech Stocks to Buy Now - Insider Monkey

Alnylam Pharmaceuticals (ALNY): Among the Oversold Biotech Stocks to Buy Now  Insider Monkey

Alnylam Pharmaceuticals (ALNY): Among the Oversold Biotech Stocks to Buy Now - Insider Monkey

Click here to get full coverage on Here's Why You Should Add ALNY Stock to Your Portfolio Right Now - Nasdaq

Here's Why You Should Add ALNY Stock to Your Portfolio Right Now  Nasdaq

Here's Why You Should Add ALNY Stock to Your Portfolio Right Now - Nasdaq

Click here to get full coverage on Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y - TradingView

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y  TradingView

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y - TradingView

Click here to get full coverage on Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference - Business Wire

Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference  Business Wire

Alnylam to Webcast Presentation at 43rd Annual J.P. Morgan Healthcare Conference - Business Wire

Click here to get full coverage on AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B - Business Wire

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B  Business Wire

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B - Business Wire

Alnylam Pharmaceuticals Inc (ALNY)

Price Chart

Key Statistics

Technicals

About ALNY

Latest News

BMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT - MSN

Alnylam Pharmaceuticals (ALNY) Price Target Raised by Wells Fargo | ALNY Stock News - GuruFocus

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga

Advanced Charts

Top Gainers

Top Losers